<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="review-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Russian Medicine</journal-id><journal-title-group><journal-title xml:lang="en">Russian Medicine</journal-title><trans-title-group xml:lang="ru"><trans-title>Российский медицинский журнал</trans-title></trans-title-group></journal-title-group><issn publication-format="print">0869-2106</issn><issn publication-format="electronic">2412-9100</issn><publisher><publisher-name xml:lang="en">Eco-Vector</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">698832</article-id><article-id pub-id-type="doi">10.17816/medjrf698832</article-id><article-id pub-id-type="edn">LICURC</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Reviews</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Научные обзоры</subject></subj-group><subj-group subj-group-type="article-type"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Oral microbiota in periodontitis and its modulation using probiotics: a review</article-title><trans-title-group xml:lang="ru"><trans-title>Микробиота полости рта при пародонтите и возможности её коррекции с использованием пробиотиков: обзор</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0003-6609-4644</contrib-id><name-alternatives><name xml:lang="en"><surname>Uzaev</surname><given-names>Ibragim Sh.</given-names></name><name xml:lang="ru"><surname>Узаев</surname><given-names>Ибрагим Шамсудинович</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>uzai.Ib2002@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0001-4525-1124</contrib-id><name-alternatives><name xml:lang="en"><surname>Ayubov</surname><given-names>Mikail B.</given-names></name><name xml:lang="ru"><surname>Аюбов</surname><given-names>Микаил Балаудинович</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>ayubowmikail@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0004-9309-265X</contrib-id><name-alternatives><name xml:lang="en"><surname>Madiev</surname><given-names>Deni A.</given-names></name><name xml:lang="ru"><surname>Мадиев</surname><given-names>Дени Асланбекович</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>madievdeni001@icloud.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0007-7711-5980</contrib-id><name-alternatives><name xml:lang="en"><surname>Shapaev</surname><given-names>Shamad S.</given-names></name><name xml:lang="ru"><surname>Шапаев</surname><given-names>Шамад Сулейманович</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>shamadshapaev@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0003-4237-5548</contrib-id><name-alternatives><name xml:lang="en"><surname>Gebekov</surname><given-names>Ilyas M.</given-names></name><name xml:lang="ru"><surname>Гебеков</surname><given-names>Ильяс Магомедгаджиевич</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>genekovilas5@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0007-1232-567X</contrib-id><name-alternatives><name xml:lang="en"><surname>Razakov</surname><given-names>Abdula S.</given-names></name><name xml:lang="ru"><surname>Разаков</surname><given-names>Абдула Саитович</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>razakov.abdula@bk.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0007-0289-5783</contrib-id><name-alternatives><name xml:lang="en"><surname>Zubayraev</surname><given-names>Deni I.</given-names></name><name xml:lang="ru"><surname>Зубайраев</surname><given-names>Дени Илесович</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>denizubair00@icloud.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0005-1920-8041</contrib-id><name-alternatives><name xml:lang="en"><surname>Kusieva</surname><given-names>Marha B.</given-names></name><name xml:lang="ru"><surname>Кусиева</surname><given-names>Марха Бекбулатовна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>kusieva2001@bk.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Noth-Ossetian State Medical Academy</institution></aff><aff><institution xml:lang="ru">Северо-Осетинская государственная медицинская академия</institution></aff></aff-alternatives><pub-date date-type="preprint" iso-8601-date="2026-03-27" publication-format="electronic"><day>27</day><month>03</month><year>2026</year></pub-date><pub-date date-type="pub" iso-8601-date="2026-05-12" publication-format="electronic"><day>12</day><month>05</month><year>2026</year></pub-date><volume>32</volume><issue>2</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>196</fpage><lpage>203</lpage><history><date date-type="received" iso-8601-date="2025-12-17"><day>17</day><month>12</month><year>2025</year></date><date date-type="accepted" iso-8601-date="2026-02-19"><day>19</day><month>02</month><year>2026</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2026, Eco-Vector</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2026, Эко-Вектор</copyright-statement><copyright-year>2026</copyright-year><copyright-holder xml:lang="en">Eco-Vector</copyright-holder><copyright-holder xml:lang="ru">Эко-Вектор</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/" start_date="2029-05-12"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://eco-vector.com/for_authors.php#07</ali:license_ref></license></permissions><self-uri xlink:href="https://medjrf.com/0869-2106/article/view/698832">https://medjrf.com/0869-2106/article/view/698832</self-uri><abstract xml:lang="en"><p>Periodontitis remains one of the leading causes of tooth loss, with disruption of microbial balance in the oral cavity considered a key mechanism in its pathogenesis. In recent years, growing interest has focused on the oral microbiota as a therapeutic target, highlighting the relevance of analyzing current approaches aimed at restoring microbial balance and reducing inflammatory activity.</p> <p>The review aimed to evaluate the effectiveness of probiotics, prebiotics, and other microbiota-modulating interventions in periodontitis. An analysis of publications from 2020 to 2025, including clinical studies and reviews, demonstrated that the use of probiotics (<italic>Lactobacillus reuteri</italic>, <italic>L. salivarius</italic>, <italic>Bifidobacterium </italic>spp.) and prebiotics (inulin) is associated with a reduction in periodontal pocket depth, decreased gingival bleeding, normalization of microbial composition, and reduced levels of proinflammatory cytokines. The most pronounced clinical effect was observed when these agents were combined with conventional mechanical debridement of root surfaces.</p> <p>The available evidence indicates that modulation of the oral microbiota represents an effective and safe adjunctive approach in the treatment of periodontitis. This review systematizes current data on the use of probiotics and prebiotics in dentistry and identifies promising directions for future clinical research aimed at optimizing treatment protocols.</p></abstract><trans-abstract xml:lang="ru"><p>Пародонтит остаётся одной из наиболее частых причин утраты зубов, при этом нарушение микробного равновесия в полости рта рассматривается как ключевое звено его патогенеза. В последние годы возрастает интерес к микробиоте как терапевтической мишени, что обусловливает актуальность анализа современных подходов, направленных на восстановление её баланса и снижение воспалительной активности.</p> <p>Целью настоящего обзора литературы стала оценка эффективности пробиотиков, пребиотиков и других средств, влияющих на микробиоту полости рта при пародонтите. Анализ публикаций 2020–2025 гг., включающих клинические исследования и обзоры, показал, что применение пробиотиков (<italic>Lactobacillus reuteri</italic>, <italic>L. salivarius</italic>, <italic>Bifidobacterium </italic>spp.) и пребиотиков (инулин) способствует снижению глубины пародонтальных карманов, уменьшению кровоточивости дёсен, нормализации микробного состава и снижению концентрации провоспалительных цитокинов. Наиболее выраженный клинический эффект наблюдается при сочетании данных средств с традиционной механической обработкой корней зубов.</p> <p>Полученные данные свидетельствуют о том, что модуляция микробиоты полости рта является эффективным и безопасным адъювантным направлением терапии пародонтита. Представленный обзор систематизирует современные сведения о применении пробиотиков и пребиотиков в стоматологии и определяет перспективные направления дальнейших клинических исследований, направленных на оптимизацию лечебных протоколов.</p></trans-abstract><kwd-group xml:lang="en"><kwd>periodontitis</kwd><kwd>oral microbiota</kwd><kwd>probiotics</kwd><kwd>prebiotics</kwd><kwd>review</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>пародонтит</kwd><kwd>микробиота полости рта</kwd><kwd>пробиотики</kwd><kwd>пребиотики</kwd><kwd>обзор литературы</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Zanatta CAR, Fritz PC, Comelli EM, Ward WE. Intervention with inulin prior to and during sanative therapy to further support periodontal health: study protocol for a randomized controlled trial. Trials. 2021;22(1):527. doi: 10.1186/s13063-021-05504-1 EDN: NRGJFU</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Mensi M, Caselli E, D’accolti M, et al. Efficacy of the additional use of subgingival air-polishing with erythritol powder in the treatment of periodontitis patients: a randomized controlled clinical trial. Part II: effect on sub-gingival microbiome. Clin Oral Investig. 2023;27(6):2547–2563. doi: 10.1007/s00784-022-04811-4 EDN: IMIOLZ</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>NĘdzi-GÓra M, WrÓblewska M, GÓrska R. The effect of lactobacillus salivarius sgl03 on clinical and microbiological parameters in periodontal patients. Pol J Microbiol. 2020;69(4):441–451. doi: 10.33073/pjm-2020-047</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Şahin T, Akca G, Özmeriç N. The role of probiotics for preventing dysbiosis in periodontal disease: a randomized controlled trial. Turk J Med Sci. 2023;54(1):357–365. doi: 10.55730/1300-0144.5798 EDN: URVAIZ</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Seidel CL, Gerlach RG, Weider M, et al. Influence of probiotics on the periodontium, the oral microbiota and the immune response during orthodontic treatment in adolescent and adult patients (ProMB Trial): study protocol for a prospective, double-blind, controlled, randomized clinical trial. BMC Oral Health. 2022;22(1):148. doi: 10.1186/s12903-022-02180-8 EDN: DSLSIL</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Gannenko AS, Miroshnichenko VV, Masimov AE. Application of bacteriophages in inflammatory periodontal disease treatment. Actual Problems in Dentistry. 2020;16(1):64–69. doi: 10.18481/2077-7566-2020-16-1-64-69 EDN: ILJRFH</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Gerasimova LP, Kamilov FH, Ibragimova IF, et al. Modern methods of chronic periodontitis treatment (literature review). Actual Problems in Dentistry. 2024;20(4):28–39. doi: 10.18481/2077-7566-2024-20-4-28-39 EDN: AGHKAR</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Kang MS, Lee DS, Lee SA, et al. Effects of probiotic bacterium Weissella cibaria CMU on periodontal health and microbiota: a randomised, double-blind, placebo-controlled trial. BMC Oral Health. 2020;20(1):243. doi: 10.1186/s12903-020-01231-2 EDN: UFJEEQ</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Žiemytė M, Lopez-Roldan A, Carda-Diéguez M, et al. Personalized antibiotic selection in periodontal treatment improves clinical and microbiological outputs. Front Cell Infect Microbiol. 2023;13:1307380. doi: 10.3389/fcimb.2023.1307380 EDN: DRALAY</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Gonçalves MLL, Sobral APT, Gallo JMAS, et al. Antimicrobial photodynamic therapy with erythrosine and blue light on dental biofilm bacteria: study protocol for randomised clinical trial. BMJ Open. 2023;13(9):e075084. doi: 10.1136/bmjopen-2023-075084 EDN: MVATTJ</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Taalab MR, Mahmoud SA, Moslemany RME, Abdelaziz DM. Intrapocket application of tea tree oil gel in the treatment of stage 2 periodontitis. BMC Oral Health. 2021;21(1):239. doi: 10.1186/s12903-021-01588-y EDN: CVEFKF</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Takesh T, Goshtasbi A, Lin K, et al. Better living through chemistry? A randomized, double-blind controlled study evaluating the efficacy of plaque control and gingival health impacts of a novel stannous fluoride-containing gel. J Periodontol. 2023;94(4):509–518. doi: 10.1002/jper.22-0254 EDN: AWWZJG</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Gurina AV, Nagaeva MO, Zaitseva MV, et al. The role of oral microbiocenosis disorders in the formation of somatic and dental pathology. Actual Problems in Dentistry. 2022;18(2):15–22. doi: 10.18481/2077-7566-2022-18-2-15-22 EDN: GDAZFO</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Yilmaz FÇ, Görgin NÇ. Yilmaz FÇ, Görgin NÇ. The role of probiotics and dietary interventions in the treatment of periodontitis: a pilot randomized controlled clinical trial. BMC Oral Health. 2025;25(1):1287. doi: 10.1186/s12903-025-06510-4 EDN: GSIICL</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Arefnia B, Klymiuk I, Peikert SA, et al. Impact of antibiotics on the subgingival microbiome in advanced periodontitis: secondary analysis of a randomized controlled trial. Diagnostics (Basel). 2025;15(16):2012. doi: 10.3390/diagnostics15162012 EDN: IOCLOV</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Kodzaeva ZS, Daurova FYu, Tomaeva DI, et al. Combined use of antimicrobial medication and physical therapeutic factors in periodontitis. Russian Journal of Dentistry. 2022;26(5):415–420. doi: 10.17816/dent.109158 EDN: GYCIMD</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Lundtorp-Olsen C, Enevold C, Twetman S, Belstrøm D. Probiotics do not alter the long-term stability of the supragingival microbiota in healthy subjects: a randomized controlled trial. Pathogens. 2021;10(4):391. doi: 10.3390/pathogens10040391 EDN: WZXUOH</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Kleine Bardenhorst S, Hagenfeld D, Matern J, et al. The role of the oral microbiota in the causal effect of adjunctive antibiotics on clinical outcomes in stage III-IV periodontitis patients. Microbiome. 2024;12(1):220. doi: 10.1186/s40168-024-01945-3 EDN: KSLDZM</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Xu X, He L, Huo P, et al. Potential short-term shift in oral microbiota of patients with stage III-IV periodontitis and type 2 diabetes treated by non-surgical periodontal therapy. J Dent Sci. 2025;20(3):1470–1479. doi: 10.1016/j.Jds.2025.01.014 EDN: XZUWLF</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Omar YK, Rashidy MAE, Ahmed GB, Aboulela AG. Evaluation of leukocyte-platelet rich fibrin as an antibiotic slow-release biological device in the treatment of moderate periodontitis: a randomized controlled clinical trial. BMC Oral Health. 2024;24(1):1530. doi: 10.1186/s12903-024-05254-x EDN: EJTBRM</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Saberi Kakhki KCL, Harks I, Matern J, et al. Association of supragingival plaque management with subgingival microbiota is moderated by adjunctive antibiotics in stage III–IV periodontitis patients during periodontal therapy. J Oral Microbiol. 2025;17(1):2517043. doi: 10.1080/20002297.2025.2517043 EDN: AUJCLQ</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Bushueva E, Grigorjev S, Sablina S, et al. Clinical and microbiological characteristics of oral cavity in patients with periodontitis and hypothyroidism on the background of complex therapy with inclusion of synbiotic. Actual Problems in Dentistry. 2021;17(2):32–37. doi: 10.18481/2077-7566-20-17-2-32-37 EDN: VZWUTY</mixed-citation></ref></ref-list></back></article>
